SHA:600267 Market Cap

SHA:600267 has a market cap or net worth of 13.32 billion as of April 29, 2026. Its market cap has increased by 25.81% in one year.

Market Cap

13.32B

Enterprise Value

15.21B

Revenue

10.31B

Ranking

n/a

PE Ratio

19.22

Stock Price

11.47

Market Cap Chart

Since August 15, 2006, SHA:600267's market cap has increased from 2.44B to 13.32B, an increase of 447.04%. That is a compound annual growth rate of 9.00%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	13.38B	16.30%
Dec 31, 2025	11.50B	18.59%
Dec 31, 2024	9.70B	-12.87%
Dec 29, 2023	11.13B	-13.94%
Dec 30, 2022	12.94B	-22.69%
Dec 31, 2021	16.73B	4.84%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Guobang Pharma	13.39B
Zhejiang Medicine	13.80B
Shenzhen Chipscreen Biosciences	13.08B
Tibet Rhodiola Pharmaceutical Holding Co.	13.02B
Beijing Aosaikang Pharmaceutical	14.13B
Shanghai Shyndec Pharmaceutical	12.86B
Shenzhen Hepalink Pharmaceutical Group	14.47B
Ningbo Menovo Pharmaceutical	12.44B

Market Cap Rankings